CommercialPrior AuthHigh impact
MPC August 2026
Blue Cross Blue Shield of Nebraska·NE · Wound Care, Podiatry, Dermatology +3 more·Medical Policy
Effective date
Aug 1, 2026
We identified it
Jun 19, 2026
Summary
Blue Cross Blue Shield of Nebraska is implementing new prior authorization requirements effective August 1, 2026 for three medical policies: amniotic membrane treatments, bioengineered skin substitutes, and sacroiliac joint pain treatment. These policies establish strict medical necessity criteria for wound care treatments including diabetic foot ulcers and venous leg ulcers.
Action Required
By August 1, 2026: Billing team must update prior authorization workflows for amniotic membrane treatments (Policy I.200), bioengineered skin substitutes (Policy I.202), and sacroiliac joint pain treatments (Policy III.189). Update billing system to flag these services for prior auth requirements. Train providers on new medical necessity criteria including 4-week conservative treatment documentation, 50% ulcer reduction failure criteria, and approved product lists. Claims will be denied without proper prior authorization.